title: Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda.
abstract: METHODS
  Kiboga district, a rural area in Central Uganda.
  
  
  OBJECTIVE
  To assess the cost and cost-effectiveness of community-based care for new smear-positive pulmonary tuberculosis patients compared with conventional hospital-based care.
  
  
  METHODS
  Costs were analysed from the perspective of health services, patients, and community volunteers in 1998 US dollars, using standard methods. Cost-effectiveness was calculated as the cost per patient successfully treated.
  
  
  RESULTS
  The cost per patient treated for new smear-positive patients was dollars 510 with the conventional hospital-based approach to care (dollars 419 for the health system and dollars 91 for patients), and dollars 289 with community-based care (dollars 227 for health services, dollars 53 for patients and dollars 9 for volunteers). Important new costs associated with community-based care included programme supervision (dollars 18 and dollars 9 per patient at central and district levels, respectively) and training (dollars 18 per patient). The cost per patient successfully treated was dollars 911 with the hospital-based strategy and dollars 391 with community-based care, reflecting both lower costs and higher effectiveness (74% vs. 56% successful treatment rate) with community-based care. Length of hospital stay fell from an average of 60 to 19 days.
  
  
  CONCLUSIONS
  There is a strong economic case for the implementation of community-based care in Uganda.
authors.affiliation: Makerere University, Kampala, Uganda.
authors.forename: D
authors.initials: D
authors.lastname: Okello
authors.forename: K
authors.initials: K
authors.lastname: Floyd
authors.forename: F
authors.initials: F
authors.lastname: Adatu
authors.forename: R
authors.initials: R
authors.lastname: Odeke
authors.forename: G
authors.initials: G
authors.lastname: Gargioni
mesh_terms: D003153:Community Health Services / Q000191:economics* / Q000706:statistics & numerical data; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D019035:Rural Health Services; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000191:economics*; D014454:Uganda